✦ LIBER ✦

A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium

✍ Scribed by Flemming Geertsen, Poul; Sengeløv, Lisa; Kornum Larsen, Susanne; von der Maase, Hans

Book ID: 122917472
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 561 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)90383-Q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of cisplatin, carboplat

A phase II study of cisplatin, carboplatin and methotrexate in patients with metastatic or locally recurrent transitional cell carcinoma of the urothelium

✍ Sengeløv, L; Nielsen, OS; Kamby, C; von der Maase, H 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A prognostic index in patients with meta

A prognostic index in patients with metastatic or recurrent transitional cell carcinoma of the urothelium (TCU)

✍ Sengeløv, L; Kamby, C; von der Maase, H 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 165 KB

COMBINATION CHEMOTHERAPY FOR METASTATIC

COMBINATION CHEMOTHERAPY FOR METASTATIC OR LOCALLY ADVANCED GENITOURINARY SQUAMOUS CELL CARCINOMA: A PHASE II STUDY OF METHOTREXATE, CISPLATIN AND BLEOMYCIN

✍ CORRAL, DAVID A.; SELLA, AVISHAY; PETTAWAY, CURTIS A.; AMATO, ROBERT J.; JONES, 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 807 KB

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

A phase II study of pemetrexed combined

A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma

✍ T.K. Yau; T. Shum; A.W.M. Lee; M.W. Yeung; W.T. Ng; L. Chan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra